Sponsors (9)
I'll give you the short version of this bill.
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Imposes targeted economic and immigration sanctions on foreign persons who knowingly participated in forced organ harvesting in China, requires the President to produce and update a list of such persons, and directs U.S. agencies to report to Congress on China’s transplant laws, practices, and related U.S. research links. The law also instructs the U.S. to avoid transplant cooperation with China, coordinate with allies on human-rights actions, and clarifies that these sanction authorities do not apply to banning imports of goods; the sanction authority sunsets after five years.
Avoid any cooperation with the People’s Republic of China in the organ transplantation field while the Chinese Communist Party remains in power.
Take appropriate measures, including using relevant sanctions authorities, to coerce the Chinese Communist Party to end any state-sponsored organ harvesting campaign.
Work with allies, partners, and multilateral institutions to highlight the People’s Republic of China’s persecution of Falun Gong.
Coordinate closely with the international community on targeted sanctions and visa restrictions.
The President must impose the sanctions described in subsection (c) on each foreign person included in the most recent list submitted under subsection (b).
Primary impacts:
People and entities in China implicated in state or state-facilitated organ procurement will face potential visa bans and economic sanctions; named foreign persons could be publicly listed and periodically updated. This raises legal, travel, and financial exposure for targeted individuals and organizations.
Victims and survivors of forced organ harvesting and persecuted groups (e.g., Falun Gong practitioners, prisoners of conscience) receive formal U.S. policy recognition and a mechanism intended to pressure perpetrators and raise international attention.
U.S. foreign-policy and health agencies (Department of State, HHS, NIH) must allocate staff and resources to compile, assess, and deliver the detailed report on China’s transplant policies and to coordinate with allies; the requirement may affect ongoing grant oversight and interagency workloads.
Academic and medical research institutions may face increased scrutiny of past and current transplant-related collaborations with Chinese partners; the Act requires a 10-year accounting of U.S. grants that supported transplant research in China or U.S.–China collaborations, which could influence future funding, collaboration risk assessments, and institutional compliance reviews.
International diplomacy and relations with allies could be affected as the U.S. seeks multilateral coordination on sanctions and visa restrictions; China may respond with countermeasures, impacting broader bilateral relations.
Businesses and trade in goods are largely insulated by the law’s explicit exclusion of import bans from its sanction authorities; however, entities providing financial services or other support to listed persons could be affected by the economic measures.
The presidential waiver, national-security exceptions, classification options, and five-year sunset make implementation dependent on executive-branch judgments, potentially producing variation in enforcement intensity over time.
Read twice and referred to the Committee on Foreign Relations.
Introduced March 3, 2025 by Rafael Edward Cruz · Last progress March 3, 2025
Expand sections to see detailed analysis
Read twice and referred to the Committee on Foreign Relations.
Introduced in Senate